Search

Your search keyword '"Andreone, Pietro"' showing total 5 results
Start Over Author "Andreone, Pietro" Publication Type Conference Materials
5 results on '"Andreone, Pietro"'

1. P134 Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis delta: results from an interim analysis of a phase 3 randomized study

Author

Wedemeyer, Heiner, primary, Aleman, Soo, additional, Brunetto, Maurizia, additional, Blank, Antje, additional, Andreone, Pietro, additional, Bogomolov, Pavel, additional, Chulanov, Vladimir, additional, Mamonova, Nina, additional, Geyvandova, Natalia, additional, Morozov, Viacheslav, additional, Sagalova, Olga, additional, Stepanova, Tatyana, additional, Manuilov, Dmitry, additional, Mercier, Renee-Claude, additional, An, Qi, additional, Flaherty, John, additional, Osinusi, Anu, additional, Lau, Audrey, additional, Wiesch, Julian Schulze zur, additional, Cornberg, Markus, additional, Zeuzem, Stefan, additional, and Lampertico, Pietro, additional

Published
2023
Full Text
View/download PDF

2. Efficacy and Safety of Bulevirtide Monotherapy Given at 2 mg or 10 mg Dose Level Once Daily for Treatment of Chronic Hepatitis Delta: Week 48 Primary Endpoint Results from a Phase 3 Randomized, Multicenter, Parallel Design Study

Author

Wedemeyer, Heiner, additional, Aleman, Soo, additional, Brunetto, Maurizia, additional, Blank, Antje, additional, Andreone, Pietro, additional, Bogomolov, Pavel, additional, Chulanov, Vladimir, additional, Mamonova, Nina, additional, Geyvandova, Natalia, additional, Morozov, Viacheslav, additional, Sagalova, Olga, additional, Stepanova, Tatyana, additional, Manuilov, Dmitry, additional, Suri, Vithika, additional, An, Qi, additional, Flaherty, John, additional, Osinusi, Anu, additional, zur Wiesch, JulianSchulze, additional, Cornberg, Markus, additional, Zeuzem, Stefan, additional, and Lampertico, Pietro, additional

Published
2023
Full Text
View/download PDF

3. PTU-009 Long-term effects of obeticholic acid in patients with primary biliary cholangitis on inflammatory markers

Author

Hirschfield, Gideon M, primary, Nevens, Frederik, additional, Shiffman, Mitchell L, additional, Drenth, Joost PH, additional, Bowlus, Christopher L, additional, Vargas, Victor, additional, Andreone, Pietro, additional, Ryder, Stephen, additional, Liberman, Alexander, additional, Malecha, Elizabeth Smoot, additional, MacConell, Leigh, additional, and Trauner, Michael, additional

Published
2019
Full Text
View/download PDF

4. IDDF2019-ABS-0108 Hepatic decompensation risk is reduced, but not eliminated after direct-acting antivirals: the role of spleen stiffness measurement

Author

Marasco, Giovanni, primary, Dajti, Elton, additional, Ravaioli, Federico, additional, Colecchia, Antonio, additional, Letizia Bacchi Reggiani, Maria, additional, Colli, Agostino, additional, Alemanni, Luigina Vanessa, additional, Tame, Maria Rosa, additional, Andreone, Pietro, additional, Brillanti, Stefano, additional, Azzaroli, Francesco, additional, Mazzella, Giuseppe, additional, and Festi, Davide, additional

Published
2019
Full Text
View/download PDF

5. IDDF2018-ABS-0107 Efficacy and safety of TENOFOVIR ALAFENAMIDE (TAF) at 96 weeks in chronic HBV (CHB) patients with risk factors for use of TENOFOVIR DISOPROXIL FUMARATE (TDF)

Author

Chan, Henry Lik-Yuen, primary, Buti, Maria, additional, Flisiak, Robert, additional, Ryder, Stephen, additional, Streinu-Cercel, Adrian, additional, Flaherty, John F, additional, Gaggar, Anuj, additional, Mo, Shuyuan, additional, Mani Subramanian, G, additional, Zoulim, Fabrian, additional, Andreone, Pietro, additional, and Marcellin, Patrick, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results